Nocturnal activity with nighttime pergolide in Par... [Neurology. 2005] - PubMed

loading

High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. [Mov Disord. 1996]
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
Facca A, Sanchez-Ramos J. Mov Disord. 1996 May; 11(3):327-9.
[Multiple latency test in a patient with episodes of sleep induced by pergolide]. [Rev Neurol. 2002]
[Multiple latency test in a patient with episodes of sleep induced by pergolide].
Jiménez-Jiménez FJ, Velasco I, de Toledo M, Sayed Y, Zurdo J, Ortí-Pareja M. Rev Neurol. 2002 Jun 16-30; 34(12):1140-1.
Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. [Mov Disord. 2003]
Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
Navan P, Findley LJ, Jeffs JA, Pearce RK, Bain PG. Mov Disord. 2003 Feb; 18(2):176-80.
Review Pergolide in the treatment of patients with early and advanced Parkinson's disease. [Clin Neuropharmacol. 2002]
Review Pergolide in the treatment of patients with early and advanced Parkinson's disease.
Bonuccelli U, Colzi A, Del Dotto P. Clin Neuropharmacol. 2002 Jan-Feb; 25(1):1-10.
Review Dopamine agonists and sleep in Parkinson's disease. [Neurology. 2002]
Review Dopamine agonists and sleep in Parkinson's disease.
Cantor CR, Stern MB. Neurology. 2002 Feb 26; 58(4 Suppl 1):S71-8.

Sleep disturbances in Parkinson's disease patients and management options. [Nat Sci Sleep. 2011]
Sleep disturbances in Parkinson's disease patients and management options.
Claassen DO, Kutscher SJ. Nat Sci Sleep. 2011; 3:125-33. Epub 2011 Dec 1.
Parkinson's disease and sleep/wake disturbances. [Parkinsons Dis. 2012]
Parkinson's disease and sleep/wake disturbances.
Swick TJ. Parkinsons Dis. 2012; 2012:205471. Epub 2012 Dec 30.
Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy? [Ther Adv Neurol Disord. 2012]
Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?
Borgohain R, Kandadai RM, Jabeen A, Kannikannan MA. Ther Adv Neurol Disord. 2012 Jan; 5(1):23-41.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
MedGen
Related information in MedGen
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled s...
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.
Neurology. 2005 Apr 26 ;64(8):1450-1.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed